Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis

Author:

Tantry Subramanyam J.1,Markad Shankar D.1,Shinde Vikas1,Bhat Jyothi1,Balakrishnan Gayathri1,Gupta Amit K.1ORCID,Ambady Anisha1,Raichurkar Anandkumar1,Kedari Chaitanyakumar1,Sharma Sreevalli1,Mudugal Naina V.1,Narayan Ashwini1,Naveen Kumar C. N.1,Nanduri Robert1,Bharath Sowmya1,Reddy Jitendar1,Panduga Vijender1,Prabhakar K. R.1,Kandaswamy Karthikeyan1,Saralaya Ramanatha1,Kaur Parvinder1,Dinesh Neela1,Guptha Supreeth1,Rich Kirsty2,Murray David2,Plant Helen2,Preston Marian2,Ashton Helen2,Plant Darren2,Walsh Jarrod2,Alcock Peter2,Naylor Kathryn2,Collier Matthew2,Whiteaker James3,McLaughlin Robert E.3,Mallya Meenakshi1,Panda Manoranjan1,Rudrapatna Suresh1,Ramachandran Vasanthi1,Shandil Radha1,Sambandamurthy Vasan K.1,Mdluli Khisi4,Cooper Christopher B.4,Rubin Harvey5,Yano Takahiro5,Iyer Pravin1,Narayanan Shridhar1,Kavanagh Stefan2,Mukherjee Kakoli1,Balasubramanian V.1,Hosagrahara Vinayak P.1,Solapure Suresh1,Ravishankar Sudha1ORCID,Hameed P Shahul1

Affiliation:

1. Innovative Medicines, AstraZeneca India Pvt. Ltd., Bellary Road, Hebbal, Bangalore 560024, India

2. AstraZeneca, Alderley Park, Mereside, Macclesfield, Cheshire U.K. SK10 4TG

3. Infection Innovative Medicines, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States

4. Global Alliance for TB Drug Development, 40 Wall Street, 24th Floor, New York, New York 10005, United States

5. University of Pennsylvania, 111 Clinical Research Building, 415 Curie Boulevard, Philadelphia Pennsylvania 19104, United States

Funder

Global Alliance for TB Drug Development

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference51 articles.

1. Global Tuberculosis Report 2015,20thed.World Health Organization:Geneva, 2015; http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf(accessed Oct 7, 2015).

2. The Population Dynamics and Control of Tuberculosis

3. Tuberculosis

4. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

5. Virtually incurable TB warns of impending disaster

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3